AAN issues top five Choosing wisely recommendations

AAN issues top five <i>Choosing wisely</i> recommendations
The American Academy of Neurology's Top Five Recommendations in the Choosing Wisely campaign, established to promote high-value neurologic medicine and to foster physician-patient communication, have been approved and issued, according to a special article published online Feb. 20 in Neurology.

(HealthDay)—The American Academy of Neurology's (AAN's) Top Five Recommendations in the Choosing Wisely campaign, established to promote high-value neurologic medicine and to foster physician-patient communication, have been approved and issued, according to a special article published online Feb. 20 in Neurology.

Annette M. Langer-Gould, M.D., Ph.D., from the Los Angeles Medical Center, and colleagues from the AAN's Choosing Wisely Working Group discuss the development of evidence-based recommendations promoting high-value neurologic medicine and physician-. Recommendations were solicited from AAN members and were reviewed externally. The Top Five Recommendations were selected using a modified Delphi process.

After approval from the AAN Practice Committee and Board of Directors, the authors reported the Top Five Recommendations: (1) not performing electroencephalography for headaches; (2) not performing imaging of carotid arteries for syncope in the absence of other ; (3) not using opioids or butalbital for migraine, except as a last resort; (4) not prescribing interferon-β or glatiramer acetate for disability associated with progressive, non-relapsing multiple sclerosis; and (5) not performing carotid endarterectomy for asymptomatic unless the complication rate is lower than 3 percent.

"Moving forward, the AAN's goal is to develop successful implementation strategies for its first Top Five list and to obtain accurate estimates of how much wasteful spending and patient harm can be prevented if these or future recommendations are followed," the authors write.

Several authors disclosed financial ties to the pharmaceutical and health care industries.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Out of danger: A neural basis for avoiding threats

4 hours ago

Researchers at the RIKEN Brain Science Institute in Japan have identified a key neuronal pathway that makes learning to avoid unpleasant situations possible. Published online in the November 20 issue of Neuron, the wo ...

New approach for treating ALS

9 hours ago

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that primarily kills motor neurons, leading to paralysis and death 2 to 5 years from diagnosis. Currently ALS has no ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.